Chemotherapy and biologic therapies for melanoma: do they work?
LB Jilaveanu, SA Aziz, HM Kluger - Clinics in dermatology, 2009 - Elsevier
The incidence of melanoma is increasing, and the therapeutic options for unresectable
disease are limited, resulting in an increase in the death rate. Melanoma is usually resistant …
disease are limited, resulting in an increase in the death rate. Melanoma is usually resistant …
State of melanoma: an historic overview of a field in transition
VC Gorantla, JM Kirkwood - Hematology/Oncology Clinics, 2014 - hemonc.theclinics.com
In 2014, an estimated 76,100 patients will develop new primary melanoma in the United
States, and 9710 will die of this disease. 1 In the United States, melanoma accounts for less …
States, and 9710 will die of this disease. 1 In the United States, melanoma accounts for less …
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
J Atzpodien, K Terfloth, M Fluck, M Reitz - British journal of cancer, 2007 - nature.com
To evaluate the efficacy of cisplatin, gemcitabine, and treosulfan (CGT) in 91 patients with
pretreated relapsed AJCC stage IV cutaneous malignant melanoma. Patients in relapse …
pretreated relapsed AJCC stage IV cutaneous malignant melanoma. Patients in relapse …
Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients
J Atzpodien, L Morawek, M Fluck, M Reitz - Cancer chemotherapy and …, 2009 - Springer
Purpose To evaluate the efficacy of bleomycin, vinorelbine, and trofosfamide (BVT) in 28
patients with pretreated relapsed AJCC stage IV cutaneous malignant melanoma. Methods …
patients with pretreated relapsed AJCC stage IV cutaneous malignant melanoma. Methods …
The role of interferon-α in a successful murine tumor therapy
TA Steele, CC Hauser - Experimental Biology and Medicine, 2005 - journals.sagepub.com
Combination therapy using reovirus type 3 and the chemotherapeutic agent 1, 3-bis (2-
chloroethyl)-1-nitrosourea (BCNU) is sufficient to cure approximately 80% of EL-4 lymphoma …
chloroethyl)-1-nitrosourea (BCNU) is sufficient to cure approximately 80% of EL-4 lymphoma …
Melanom in der Schwangerschaft
K Wiedemeyer, P Mayser - Die Gynäkologie, 2005 - search.proquest.com
In der Literatur existieren teilweise erschreckende Fallberichte über den Verlauf von
malignen Melanomen in der Schwangerschaft mit Vermutungen über einen negativen …
malignen Melanomen in der Schwangerschaft mit Vermutungen über einen negativen …
Dual Role of Pituitary adenylate cyclase activating polypeptide (PACAP) in Melanoma: Autocrine and Paracrine Mechanisms on Tumor and Immune cells
SK Choi - 2015 - archiv.ub.uni-marburg.de
This thesis is based on investigation of PACAP and PAC1R expression and functional roles
of PACAP in human melanoma as well as immune cells. In the first part, the study …
of PACAP in human melanoma as well as immune cells. In the first part, the study …
Melanoma and pregnancy
K Wiedemeyer, P Mayser - Der Gynäkologe, 2005 - Springer
In der Literatur existieren teilweise erschreckende Fallberichte über den Verlauf von
malignen Melanomen in der Schwangerschaft mit Vermutungen über einen negativen …
malignen Melanomen in der Schwangerschaft mit Vermutungen über einen negativen …
[引用][C] Mechanisms of Antiproliferative Signaling by Indole-3-carbinol in Human Breast and Skin Cancer Cells
I Aronchik - 2009 - University of California, Berkeley